Prognostic Significance of Albumin Levels Prior to Treatment in Patients With Head and Neck Squamous Cell Carcinoma

2020 ◽  
Vol 71 (4) ◽  
pp. 204-211
Author(s):  
Xavier León ◽  
Laura Pardo ◽  
Aina Sansa ◽  
Rocio Puig ◽  
Cristina Serrano ◽  
...  
2021 ◽  
Vol 10 ◽  
Author(s):  
Chengzhi Xu ◽  
Yunbin Zhang ◽  
Yupeng Shen ◽  
Yong Shi ◽  
Ming Zhang ◽  
...  

BackgroundHead and neck squamous cell carcinoma (HNSCC) is a leading cancer with high morbidity and mortality worldwide. The aim is to identify genes with clinical significance by integrated bioinformatics analysis and investigate their function in HNSCC.MethodsWe downloaded and analyzed two gene expression datasets of GSE6631 and GSE107591 to screen differentially expressed genes (DEGs) in HNSCC. Common DEGs were functionally analyzed by Gene ontology and KEGG pathway enrichment analysis. Protein-protein interaction (PPI) network was constructed with STRING database and Cytoscape. ENDOU was overexpressed in FaDu and Cal-27 cell lines, and cell proliferation and migration capability were evaluated with MTT, scratch and transwell assay. The prognostic performance of ENDOU and expression correlation with tumor infiltrates in HNSCC were validated with TCGA HNSCC datasets.ResultsNinety-eight genes shared common differential expression in both datasets, with core functions like extracellular matrix organization significantly enriched. 15 genes showed prognostic significance, and COBL and ENDOU serve as independent survival markers in HNSCC. In-vitro ENDOU overexpression inhibited FaDu and Cal-27 cells proliferation and migration, indicating its tumor-suppressing role in HNSCC progression. GSEA analysis indicated ENDOU down-stream pathways like DNA replication, mismatch repair, cell cycle and IL-17 signaling pathway. ENDOU showed relative lower expression in HNSCC, especially HPV-positive HNSCC samples. At last, ENDOU showed negative correlation with tumor purity and tumor infiltrating macrophages, especially M2 macrophages.ConclusionThis study identified ENDOU as a biomarker with prognostic significance in HNSCC progression.


2011 ◽  
Vol 17 (11) ◽  
pp. 3733-3741 ◽  
Author(s):  
Marlon Lindenbergh-van der Plas ◽  
Ruud H. Brakenhoff ◽  
Dirk J. Kuik ◽  
Marijke Buijze ◽  
Elisabeth Bloemena ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 6061-6061
Author(s):  
Theodoros Rampias ◽  
Margaritis Avgeris ◽  
Maria Vassilakopoulou ◽  
Veronique Neumeister ◽  
Nikos Haralambakis ◽  
...  

2002 ◽  
Vol 33 (7) ◽  
pp. 708-714 ◽  
Author(s):  
Oreste Gallo ◽  
Emanuela Masini ◽  
Benedetta Bianchi ◽  
Luca Bruschini ◽  
Milena Paglierani ◽  
...  

2001 ◽  
Vol 110 (3) ◽  
pp. 221-228 ◽  
Author(s):  
Benjamin D. Smith ◽  
Bruce G. Haffty ◽  
Clarence T. Sasaki

Head and neck squamous cell carcinoma affects more than 500,000 people worldwide each year. Despite optimal treatment with surgery, irradiation, and chemotherapy, disease recurrence and progression remains a common and challenging oncological problem. Recently, interest has developed in identifying novel molecular markers that allow identification of those patients at increased risk for locoregional recurrence and death. This article reviews several such molecular markers studied in head and neck cancer, including p53, angiogenesis-related markers, cyclin D1, and epidermal growth factor receptor. The biological function of these markers and the potential clinical implications are discussed. The purpose of this review is to update the otolaryngologist on a rapidly emerging segment of applied translational research in our field.


Sign in / Sign up

Export Citation Format

Share Document